Editorial: liver and kidney injury from remdesivir-an issue not as much as its purpose

Aliment Pharmacol Ther. 2022 Jun;55(11):1456. doi: 10.1111/apt.16921.

Authors

Shireesha Vuppalanchi¹, Raj Vuppalanchi²

Affiliations

¹ Indiana Department of Health, Indianapolis, Indiana, USA.
² Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, Indiana, USA.

PMID: 35538355
DOI: 10.1111/apt.16921

No abstract available

Publication types

Editorial
Comment

MeSH terms

Adenosine Monophosphate / adverse effects
Adenosine Monophosphate / analogs & derivatives
Alanine* / adverse effects
Alanine* / analogs & derivatives
Humans
Kidney*
Liver

Substances

remdesivir
Adenosine Monophosphate
Alanine